Peyton R. Howell - 21 May 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Peyton R. Howell
Issuer symbol
TNDM
Transactions as of
21 May 2025
Net transactions value
+$90,548
Form type
4
Filing time
23 May 2025, 16:03:22 UTC
Previous filing
24 May 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Howell Peyton R Director 12400 HIGH BLUFF DRIVE, SAN DIEGO /s/ Rachel Malina, Attorney-in-Fact for Peyton R. Howell 23 May 2025 0001528056

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $90,548 +4,387 +26% $20.64 21,077 22 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -4,387 -100% $0.000000 0 22 May 2025 Common Stock 4,387 Direct F1, F2, F3
transaction TNDM Restricted Stock Unit Award $0 +8,759 $0.000000 8,759 21 May 2025 Common Stock 8,759 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F2 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F3 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
F4 Awarded on May 21, 2025 pursuant to the 2023 Plan.